Anne Armstrong
Christie NHS Foundation Trust · The Christie NHS Foundation Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anne Armstrong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:34 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05093426 · PERSONAL - Sleep In Breast CancerClosed Loop Medicine · completed · Insomnia, Breast Cancer · principal investigator
- Ph2NCT04188119 · A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerThe Christie NHS Foundation Trust · withdrawn · Breast Cancer · principal investigator
- Ph2NCT03794596 · A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerThe Christie NHS Foundation Trust · withdrawn · Breast Cancer · principal investigator
- Ph1/Ph2NCT01791985 · AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)Imperial College London · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Validation of a Prenatal Alcohol and Drug Screening ToolR01AA014386 · NIAAA · KAISER FOUNDATION HEALTH PLAN · fiscal years 2005 to 2008 · $476,322 awarded in 2008Same name and institution; not confirmed by an ID
- HOW MUCH DOES SHE REALLY DRINK? AN HMO INTERVENTIONR01AA012486 · NIAAA · KAISER FOUNDATION RESEARCH INSTITUTE · fiscal years 2003 · $336,282 awarded in 2003Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:34 UTC. The ranking covers the 200 most relevant of 31 PubMed records, and a shared surname and initials can bring in a namesake. All 31 on PubMed
- 2,672 citationsRCR 86.7
- 619 citationsRCR 21.9
- 548 citationsRCR 19.1
- 465 citationsRCR 13.9
- 399 citationsRCR 26.2
- Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet Oncol · 2014390 citationsRCR 10.4
- 345 citationsRCR 30.7
- 108 citationsRCR 8.6
- VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.Clin Cancer Res · 202288 citationsRCR 5.2
- 83 citationsRCR 2.8